Top Markets
#1 EXOD EXOD +56.80%
#2 Cysic Cysic +11.67%
#3 Arowana Arowana +8.48%
#4 Fake World Assets Fake World Assets +5.30%
#5 Biconomy Biconomy +5.25%
#6 Cap Cap +5.11%
#7 Collect on Fanable Collect on Fanable +4.95%
#8 Apro Apro +4.87%
#9 The Black Bull The Black Bull +3.81%
#10 Dual Dual +3.59%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Beryl Drugs Limited Beryl Drugs Limited

Beryl Drugs Limited

BERLDRG
Rangering i aksjer #38015
Beryl Drugs Limited focuses on the manufacturing of bulk pharmaceutical... Beryl Drugs Limited focuses on the manufacturing of bulk pharmaceutical ingredients. Its comprehensive product portfolio encompasses liquid and dry small-volume injectable medications, ophthalmic and otic solutions, intravenous (IV) fluids supplied in both polypack and glass bottles, and a variety of veterinary pharmaceuticals. The company was established on August 24, 1993, and maintains its corporate headquarters in Indore, India.
Aksjekurs
$0.25327338
Sist synkronisert: 2026-08-14
Markedsverdi
$1.28M
Endring (1 dag)
-0.99%
Endring (1 år)
9.52%
Land
IN
Handel Beryl Drugs Limited (BERLDRG)

Kategori

Healthcare
P/B-forhold for Beryl Drugs Limited (BERLDRG)
P/B-forhold per 2026 TTM: 0
Ifølge Beryl Drugs Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Beryl Drugs Limited fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.6634 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0941 -
US